Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study

By Alemao Evo  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 349-355

Adis International

Access to resources Recommend Favorite

Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary: The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study

By Paragh György  

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 647-660

Adis International

Access to resources Recommend Favorite

Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3-year follow-up

By Rallidis Loukianos S   Kotakos Christos   Sourides Vassilios   Varounis Christos   Charalampopoulos Athanasios   Zolindaki Maria   Dagres Nikolaos   Papadopoulos Costas   Anastasiou-Nana Maria  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1481-1489

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol and plasma lipid modifying patents

By Suckling K.E.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. : 1415-1423

Informa Healthcare

Access to resources Recommend Favorite

Haemoglobin A1c Goal Attainment in Relation to Dose in Patients with Diabetes Mellitus Taking Metformin: A Nested, Case-Control Study

By Beest Fernie J.A. Penning-van  

Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. : 487-493

Adis International

Access to resources Recommend Favorite